GRIFOLS | GRF - Net Income


GRIFOLS reported EUR154M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Alcon AG USD 189M 28M Mar/2026
Almirall EUR 19.58M 7M Dec/2025
Amadeus IT EUR 343.7M 13.3M Jun/2026
Amarin USD -1.22M 6.51M Dec/2025
argenx SE USD 472M 106M Jun/2026
AstraZeneca USD 2.51B 573M Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Cie Automotive EUR 149.91M 35.97M Dec/2025
Demant DKK 427M 690M Dec/2025
Ence Energia y Celulosa EUR -17.6M 14.86M Mar/2026
Essilor EUR 1.57B 638M Jun/2026
Ferrovial EUR 258M 90M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Inditex EUR 1.38B 223M Mar/2026
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Merck EUR 659M 340M Mar/2026
Novartis USD 3.26B 108M Jun/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
Smith & Nephew USD 303M 10M Jun/2026
UCB EUR 1.08B 608M Dec/2025
Viscofan EUR 37.65M 3.98M Jun/2026